Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,11S,14S,20S,23S,26S,32S,35S,38S,41S,44S,50S,53S,56S,59S,62S,65S)-5-((1H-imidazol-5-yl)methyl)-68-amino-20,32,44-tris(4-aminobutyl)-2-benzyl-59-((S)-sec-butyl)-8-(2-carboxyethyl)-41,53-bis(hydroxymethyl)-14,26,35,56-tetraisobutyl-11,23,38,50,62,65-hexamethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67-docosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66-docosaazaoctahexacontan-1-oic acid
ID: ALA5082601
PubChem CID: 166628647
Max Phase: Preclinical
Molecular Formula: C100H169N29O27
Molecular Weight: 2209.63
Molecule Type: Unknown
Associated Items: